Oral Anticoagulant Therapy: Efficacy, Safety and the Low-Dose Controversy

Publisher： Karger

E-ISSN： 1424-8840|29|2-3|150-165

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.29, Iss.2-3, 2000-01, pp. : 150-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Efficacy of Low-Dose Oral Immunotherapy for Hen's Egg Allergy in Children

By  

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2017-01 ,pp. : 265-268

Karger

Access to resources Recommend Favorite

The Safety and Efficacy of Low‐dose Tissue Plasminogen Activator in the Treatment of Systemic Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 9, 1995-09 ,pp. : 637-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Guide to Oral Anticoagulant Therapy

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 1, 2004-11 ,pp. : 1-46

Karger

Access to resources Recommend Favorite

Efficacy of Combined Therapy with Cyclosporin and Low-Dose Prednisolone in Interstitial Pneumonia Associated with Connective Tissue Disease

By  

Respiration, Vol. 87, Iss. 6, 2014-02 ,pp. : 469-477

Karger

Access to resources Recommend Favorite

Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis

By Lazzari M.   Sabato A. F.   Caldarulo C.   Casali M.   Gafforio P.   Marcassa C.   Leonardis F.  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 555-564

Informa Healthcare

Access to resources Recommend Favorite